All Stories

  1. The influence of the antithymocyte globulin dose on clinical outcomes of patients undergoing kidney retransplantation
  2. Early conversion of pediatric kidney transplant patients to everolimus with reduced tacrolimus and steroid elimination: Results of a randomized trial
  3. Genetic diversity of Pneumocystis jirovecii from a cluster of cases of pneumonia in renal transplant patients: Cross-sectional study
  4. The effect of anti-thymocyte globulin and everolimus on the kinetics of cytomegalovirus viral load in seropositive kidney transplant recipients without prophylaxis
  5. Ureterocalicostomy with lower pole nephrectomy in a renal transplant: A case report
  6. The influence of mTOR inhibitors on the incidence of CMV infection in high-risk donor positive-recipient negative (D+/R−) kidney transplant recipients
  7. Sexual acquisition of HIV infection after solid organ transplantation: Late presentation and potentially fatal complications
  8. Regional differences in the management and outcome of kidney transplantation in patients with human immunodeficiency virus infection: A 3-year retrospective cohort study
  9. Influence ofABCC2, CYP2C8, andCYP2J2Polymorphisms on Tacrolimus and Mycophenolate Sodium-Based Treatment in Brazilian Kidney Transplant Recipients
  10. Association of the PPP3CA c.249G>A variant with clinical outcomes of tacrolimus-based therapy in kidney transplant recipients
  11. Reduced Incidence of Cytomegalovirus Infection in Kidney Transplant Recipients Receiving Everolimus and Reduced Tacrolimus Doses
  12. TRANSFORM: a novel study design to evaluate the effect of everolimus on long-term outcomes after kidney transplantation
  13. Impact of everolimus: update on immunosuppressive therapy strategies and patient outcomes after renal transplantation